
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PP2B-Aγ CRISPR/Cas9 KO Plasmid (m) | sc-422385 | 20 µg | $397.00 |
Ppp3cc encodes the gamma catalytic subunit of calcineurin (PP2B-Aγ), a Ca2+/calmodulin-dependent serine/threonine phosphatase that couples intracellular calcium signals to dephosphorylation programs controlling transcription and cytoskeletal dynamics. PP2B-Aγ contributes to calcium-dependent signaling networks such as NFAT regulation, synaptic activity–associated remodeling, and stimulus-dependent gene expression across excitable and immune-related cell types. Through modulation of phosphorylation states on key signaling intermediates, calcineurin influences processes including neuronal plasticity, development, and cell-state transitions. Dysregulated calcineurin pathway activity is widely investigated in contexts of neurobiology and immune signaling, providing disease-relevant frameworks for mechanistic studies of calcium-driven transcriptional control.
PP2B-Aγ CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Ppp3cc gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Ppp3cc together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Ppp3cc open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PP2B-Aγ protein expression.
This CRISPR knockout system enables efficient generation of Ppp3cc-deficient cell models for investigation of PP2B-Aγ signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.